Samuel T. Barnett

Director/Board Member at Friends Life Care Partners

Consumer Services

Health Technology

Health Services

Profile

Samuel T.
Barnett is currently a Director at Friends Life Care Partners.
Previously, he was a Director at Astralis Ltd.
from 2004 to 2007.
He holds a graduate degree and a doctorate from Temple University (Pennsylvania) and an undergraduate degree from Wesleyan University.

Samuel T. Barnett active positions

Companies	Position	Start
Friends Life Care Partners Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA.	Director/Board Member	-

All active positions of Samuel T. Barnett

Former positions of Samuel T. Barnett

Companies	Position	End
Astralis Ltd. Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ.	Director/Board Member	2007-03-06

See the detail of Samuel T. Barnett's experience

Training of Samuel T. Barnett

Wesleyan University	Undergraduate Degree
Temple University (Pennsylvania)	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Samuel T. Barnett's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Astralis Ltd. Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ.	Health Technology
Friends Life Care Partners Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA.	Health Services